Two epidemiological studies provided the first evidence of leptin as a potential novel therapeutic target in ALS [12,40], although very little is known about the direct influence of leptin in altering energy metabolism and disease progression in ALS, as it has thus far been correlated with the protection exerted by increased fat mass stores. The gene discussed is LEP; the disease is amyotrophic lateral sclerosis.